Brief: Hydration Pharmaceuticals Says Q2 Fy2022 Net Sales Of Us$2.0M, Up 42% On Pcp
07/07/2022 02:24
July 7 (Reuters) - Hydration Pharmaceuticals Co Ltd
HPC.AX :
* Q2 FY2022 NET SALES OF US$2.0M, UP 42% ON PCP
Source text for Eikon: ID:nASX7N3y81
Further company coverage: HPC.AX
Recent news on Hydration Pharmaceuticals
See all newsBrief: Hydration Pharmaceuticals Launches Pro Rata Entitlement Offer To Raise Up To A$1.43 MLN
Australia's Hydration Pharmaceuticals soars on upbeat monthly sales
Australia's Hydration Pharmaceuticals soars 144% on asset sale to US co
Brief: Hydration Pharmaceuticals Announces Divesture Of Hydralyte's Non-US Assets
Brief: Hydration Pharmaceuticals Says Adem Karafili Appointed Non-Executive Chairman